J&J’s China-Local Strategy Shows Risks to American Drug Export Growth — Panjiva


J&J’s China-Local Strategy Shows Risks to American Drug Export Growth

China 1761 Health Care 108 Tariff Quote Watch 92 U.S. 3306

Johnson & Johnson will invest $580 million to build two new factories in China. J&J China’s Chairman, Vladimir Makatsaria, has indicated that the Chinese government is improving intellectual property controls for healthcare products. The latter driven the U.S. government’s tariffs on Chinese exports of pharmaceuticals but have had little impact on shipments, which in total across all manufacturers surged 41.6% higher on a year earlier in the third quarter. Exports from the U.S. to China are not subject to additional duties but may fall if more U.S. manufacturers fol...

PANJIVA RESEARCH is a service provided by Panjiva, Inc. ("Panjiva") to relevant global subscribers, and are deemed to be Panjiva "Services" subject to the Panjiva Terms & Conditions of Use. Information contained within or made available via the Services is for informational purposes only and nothing in the Services shall constitute or be construed as an offering of financial instruments, or as investment advice or recommendations by Panjiva, Inc. or its affiliates of an investment strategy or whether to "buy", "sell" or "hold" an investment. The Services may include views and commentary about customers of Panjiva. No aspect of the Services is based on consideration of your individual circumstances, and you should determine on your own whether you agree with the information contained within or made available via the Services. Employees involved in Panjiva Research may hold positions in securities analyzed or discussed in the Services. Panjiva does not make any express or implied warranties, representations, endorsements or conditions with respect to the Services and the information contained within or made available via the Services, including without limitation, warranties as to the usefulness, completeness, accuracy, currentness, reliability or sufficiency of any information (including, without limitation, conclusions, statements, opinions, estimates, forecasts or projections of any kind) and expressly disclaims any implied warranties. Neither this disclaimer nor any of its contents may be forwarded or redistributed without the prior written consent of Panjiva. © 2019 Panjiva, Inc. All Rights Reserved.